Tech On Drugs - Episode 4 - Dr. Emanuele de Rinaldis, Sanofi

What will the future of precision medicine look like 5-10 years down the line? And how will AI accelerate this future?

I asked Dr. Emanuele de Rinaldis to answer this and many other questions.

Emanuele is VP, Global Head of Precision Medicine & Computational Biology at Sanofi R&D.

He believes that AI will help us define new taxonomies of diseases. We will identify different types of Asthma, different types of Fibrosis.

And AI will help us create a new textbook – not one driven by just clinical observations, but a textbook driven by genetics and gene expression, together with real world evidence.

This will take drug development and precision medicine to a level we have never seen before.